showing that TDCPP and TDBPP decreased viability fluorescence in hESCs differentiated in in vitro spermatogenic conditions. 5,000 events were analyzed, with five replications performed for each condition for A-E. Three replications were analyzed for F-I. Significant changes in cell viability were determined using a 1-way analysis of variance (1-way ANOVA) and validated via a Student's t-test, where * is p<0.05, ** is p<0.01, and *** is p<0.001. Data are represented as mean ± SEM.
Impacts of HBCDD and TBBPA Exposure on Spermatogenesis Impacts of HBCDD and TBBPA Exposure on Spermatogenesis showing that TDCPP and TDBPP reduce average PLZF+ area in spermatogonia derived under in vitro spermatogenic conditions. (G-H) Graphical representation showing that TDCPP and TDBPP reduce average PLZF+ intensity in spermatogonia. mRNA transcript levels were normalized to 0.2% DMSO-only control. Two separate replications were performed in duplicate (n=4) for each condition. Significant changes in mRNA steady state levels were determined using Bio-Rad CFX Manager™ Software (Bio-Rad, Hercules, CA). Five replications were performed for each condition for PLZF immunostaining for E-H. Three replications were performed for B-D. Significant changes in PLZF+ area and intensity were determined using a 1-way analysis of variance (1-way ANOVA) and validated via a Student's t-test, where * is p<0.05, ** is p<0.01, and *** is p<0.001. Data are represented as mean ± SEM.
Impacts of HBCDD and TBBPA Exposure on Spermatogenesis Impacts of HBCDD and TBBPA Exposure on Spermatogenesis TDBPP impact average total HILI+ intensity in primary spermatocytes. mRNA transcript levels were normalized to 0.2% DMSO-only control. Two separate replications were performed in duplicate (n=4) for each condition. Significant changes in mRNA steady state levels were determined using Bio-Rad CFX Manager™ Software (Bio-Rad, Hercules, CA). Five replications were performed for each condition for HILI immunostaining for C-F. Three replications were performed for B. Significant changes in HILI+ area and intensity were determined using a 1-way analysis of variance (1-way ANOVA) and validated via a Student's t-test, where * is p<0.05, ** is p<0.01, and *** is p<0.001. Data are represented as mean ± SEM. showing that TDCPP and TDBPP exposure increases the percentage of haploid cells in spermatogenic cells derived from hESCs. 5,000 events were analyzed, with five replications performed for each condition. Significant changes in percentages of haploid cells and cells in G0/G1, S phase, and G2 were determined using a 1-way analysis of variance (1-way ANOVA) and validated via a Student's t-test, where * is p<0.05, ** is p<0.01, and *** is p<0.001. Data are represented as mean ± SEM. showing that TDCPP and TDBPP decrease the GSH/GSSG ratio of hESCs differentiated in in vitro spermatogenic conditions. 5,000 events were analyzed, with three replications performed for each condition for A-C. Three replications were performed for each condition for D-E. Significant changes in ROS generation and GSH/GSSG ratio were determined using a 1-way analysis of variance (1-way ANOVA) and validated via a Student's t-test, where * is p<0.05, ** is p<0.01, and *** is p<0.001. Data are represented as mean ± SEM. spermatogenic conditions. 5,000 events were analyzed, with three replications performed for each condition. Significant changes in mitochondrial potential and live cells were determined using a 1-way analysis of variance (1-way ANOVA) and validated via a Student's t-test, where * is p<0.05, ** is p<0.01, and *** is p<0.001. Data are represented as mean ± SEM.
TRANSPARENT METHODS CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dr. Charles A. Easley IV (cae25@uga.edu). As per agreement with WiCell Stem Cell Bank, NIH-approved WA01 male hESCs must be obtained directly from WiCell. STO feeder cells required for in vitro spermatogenic differentiation can be obtained through the MMRRC.
EXPERIMENTAL MODEL AND SUBJECT DETAILS Cell culture of H1 ESCs
NIH-approved WA01 (H1, WiCell, Madison, WI) male hESCs were cultured and maintained in mTeSR1 (STEMCELL Technologies, Vancouver, Canada) on matrigel (Corning Life Sciences, Tewksbury, MA) as previously described (Easley et al., 2012) . Cell authentication was performed by WiCell but validated by the Easley lab. Markers for pluripotency (Oct4, Sox2, Nanog, SSEA4, TRA-1-60, and TRA-1-81) were examined by immunocytochemistry. Routine karyotyping to ensure proper chromosomal content and lack of translocation was performed every 4-6 months through WiCell's karyotyping core service.
METHOD DETAILS Differentiation and chemical treatment of H1 ESCs
Direct differentiation into spermatogenic lineages was performed as described (Easley et al., 2012 , Easley et al., 2015 . Briefly, differentiating cells were maintained on mitomycin C-inactivated mouse STOs in mouse spermatogonial stem cell (SSC) medium containing the following (all from MilliporeSigma, St. Louis, MO, unless noted): MEMalpha (Invitrogen, Waltham, MA), 0.2% Bovine Serum Albumin, 5 µg/ml insulin, 10 µg/ml transferrin, 60 µM putrescine, 2 mM L-glutamine (Invitrogen, Waltham, MA), 50 µM β-mercaptoethanol, 1 ng/ml hbFGF (human basic fibroblast growth factor, PeproTech, Rocky Hill, NJ), 20 ng/ml GDNF (glial-derived neurotrophic factor, PeproTech, Rocky Hill, NJ), 30 nM sodium selenite, 2.36 µM palmitic acid, 0.21 µM palmitoleic acid, 0.88 µM stearic acid, 1.02 µM oleic acid, 2.71 µM linoleic acid, 0.43 µM linolenic acid, 10 mM HEPES, and 0.5X penicillin/streptomycin (Invitrogen, Waltham, MA) for ten days. Media changes occurred every two days. On day nine of the differentiation, cells were treated with 1 µM, 10 µM, 25 µM, 50 µM, 100 µM, and 200 µM of HBCDD (MilliporeSigma, St. Louis, MO) and TBPPA (Tokyo Chemical Industry Co., Ltd. (TCI), Portand, OR) for twenty-four hours. HBCDD and TBBPA were dissolved in dimethyl sulfoxide (DMSO) to create 100 mM stock solutions for use. Cells were collected on day 10 using TrypLE™ Express (Thermofisher, Waltham, MA).
Cell viability and apoptosis
Cell viability was assessed by measuring the percent of apoptotic cells in our cultures using the Muse® Annexin V and Dead Cell Assay Kit (MilliporeSigma, Billerica, MA) by staining with Annexin V and 7-AAD as per manufacturer's instructions to prepare samples for flow cytometry. Samples were run on the Muse® benchtop flow cytometer (MilliporeSigma, Billerica, MA). For each flow cytometry-based experiment, 5,000 events were analyzed for five replications. Cell viability results were verified using the Promega ApoTox-Glo TM Triplex Assay (Promega, Madison, WI) by staining with GF-AFC substrate and bis-AAF-R110 substrate as per manufacturer's instructions. Samples were assessed in triplicate using the Promega GloMax® Explorer (Promega, Madison, WI).
Mitochondrial membrane potential
Mitochondrial membrane potential was assessed by the Muse® MitoPotential Kit (MilliporeSigma, Billerica, MA) by staining with a supplied cationic, lipophilic dye and 7-AAD as per manufacturer's instructions to prepare samples for flow cytometry. Samples were run on the Muse® benchtop flow cytometer (MilliporeSigma, Billerica, MA) . For each flow cytometry-based experiment, 5,000 events were analyzed for three replications. Time points collected at 0.5 hr., 1.5 hr., 3 hr., 6 hr., 9 hr., and 12 hr. following exposure to 100 µM HBCDD and TBBPA were also performed in triplicate as described.
Reactive oxygen species (ROS) generation
ROS generation was assessed by the Muse® Oxidative Stress Kit (MilliporeSigma, Billerica, MA) by staining with dihydroethidium as per manufacturer's instructions to prepare samples for flow cytometry. Samples were run on the Muse® benchtop flow cytometer (MilliporeSigma, Billerica, MA) . For each flow cytometry-based experiment, 5,000 events were analyzed for three replications. ROS results were verified using the Promega GSH/GSSG-Glo TM Assay (Promega, Madison, WI) as per manufacturer's instructions. Samples were assessed in triplicate using the Promega GloMax® Explorer (Promega, Madison, WI). Time points collected at 0.5 hr., 1.5 hr., 3 hr., 6 hr., 9 hr., and 12 hr. following exposure to 100 µM HBCDD and TBBPA were performed in triplicate utilizing the Muse® Oxidative Stress Kit. l-Sulforaphane Rescue l-Sulforaphane (Sigma-Aldrich, St. Louis, MO) rescue of ROS mediated cell death was performed by treating cells with 1 µM l-sulforaphane for twelve hours prior to chemical treatment. Cell viability was assessed as described with the Muse® Annexin V and Dead Cell Assay Kit (MilliporeSigma, Billerica, MA). Conditions were performed in triplicate.
Haploid cell production and cell cycle progression
Haploid cell production and cell cycle progression were assessed by generating cell cycle plots revealing haploid cell, G0/G1, S phase, and G2 peaks using the Muse® Cell Cycle Assay Kit (MilliporeSigma, Billerica, MA) by staining with propidium iodide as per manufacturer's instructions to prepare samples for flow cytometry. Samples were run on the Muse® benchtop flow cytometer (MilliporeSigma, Billerica, MA). For each flow cytometry-based experiment, 5,000 events were analyzed for five replications. Haploid peaks were analyzed using guavaSoft™ 3.1.1 (MilliporeSigma, Billerica, MA).
Spermatogonial cell lineage markers
PLZF (promyelocytic leukemia zinc finger, R&D System, Minneapolis, MN) and HILI (piwi like RNA-mediated gene silencing 2, Abcam, Cambridge, MA) immunostaining was performed as previously described (Easley et al., 2012) . Briefly, cells were stained with 1.25 µg/mL PLZF or 2.25 µg/mL HILI following fixation with 4% paraformaldehyde and blocking with 4% bovine serum albumin (BSA) in 0.1% Triton X. High content imaging of differentiated hESCs was performed on the ThermoFisher Cellomics ArrayScan® VTI (Thermofisher, Waltham, MA). Quantitative analyses for average PLZF+ and HILI+ total colony area and average total intensity of PLZF+ and HILI+ staining per colony were determined using HCS Studio™ 2.0 Cell Analysis Software included with the ArrayScan® suite. Five replications were performed per condition, with three replications performed for PLZF and HILI recovery assays assessing 100 µM HBCDD and TBBPA exposure. Results were validated via qRT-PCR for PLZF and HILI mRNA transcripts using the Bio-
